| 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial M Than, L Cullen, S Aldous, WA Parsonage, CM Reid, J Greenslade, ... Journal of the American College of Cardiology 59 (23), 2091-2098, 2012 | 490 | 2012 |
| A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study M Than, L Cullen, CM Reid, SH Lim, S Aldous, MW Ardagh, WF Peacock, ... The Lancet 377 (9771), 1077-1084, 2011 | 437 | 2011 |
| Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome L Cullen, C Mueller, WA Parsonage, K Wildi, JH Greenslade, ... Journal of the American College of Cardiology 62 (14), 1242-1249, 2013 | 361 | 2013 |
| Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function ZH Endre, JW Pickering, RJ Walker, P Devarajan, CL Edelstein, ... Kidney international 79 (10), 1119-1130, 2011 | 357 | 2011 |
| Coenzyme Q10: an independent predictor of mortality in chronic heart failure SL Molyneux, CM Florkowski, PM George, AP Pilbrow, CM Frampton, ... Journal of the American College of Cardiology 52 (18), 1435-1441, 2008 | 320 | 2008 |
| Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis JW Pickering, MP Than, L Cullen, S Aldous, E Ter Avest, R Body, ... Annals of internal medicine 166 (10), 715-724, 2017 | 287 | 2017 |
| Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial) ZH Endre, RJ Walker, JW Pickering, GM Shaw, CM Frampton, ... Kidney international 77 (11), 1020-1030, 2010 | 283 | 2010 |
| Glycine betaine and glycine betaine analogues in common foods FJ De Zwart, S Slow, RJ Payne, M Lever, PM George, JA Gerrard, ... Food chemistry 83 (2), 197-204, 2003 | 272 | 2003 |
| Cystatin C–a paradigm of evidence based laboratory medicine JSC Chew, M Saleem, CM Florkowski, PM George The Clinical Biochemist Reviews 29 (2), 47, 2008 | 258 | 2008 |
| Familial hypercholesterolaemia: a model of care for Australasia GF Watts, DR Sullivan, N Poplawski, F Van Bockxmeer, I Hamilton-Craig, ... Atherosclerosis Supplements 12 (2), 221-263, 2011 | 257 | 2011 |
| Familial hypercholesterolaemia: a model of care for Australasia GF Watts, DR Sullivan, N Poplawski, F Van Bockxmeer, I Hamilton-Craig, ... Atherosclerosis Supplements 12 (2), 221-263, 2011 | 257 | 2011 |
| The significance of haemochromatosis gene mutations in the general population: implications for screening MJ Burt, PM George, JD Upton, JA Collett, CMA Frampton, TM Chapman, ... Gut 43 (6), 830-836, 1998 | 249 | 1998 |
| Effect of coenzyme Q10 supplementation on simvastatin-induced myalgia JM Young, CM Florkowski, SL Molyneux, RG McEwan, CM Frampton, ... The American journal of cardiology 100 (9), 1400-1403, 2007 | 240 | 2007 |
| Betaine and trimethylamine-N-oxide as predictors of cardiovascular outcomes show different patterns in diabetes mellitus: an observational study M Lever, PM George, S Slow, D Bellamy, JM Young, M Ho, CJ McEntyre, ... PloS one 9 (12), e114969, 2014 | 239 | 2014 |
| Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance BI Shand, RS Scott, PA Elder, PM George Diabetes, Obesity and Metabolism 5 (5), 349-353, 2003 | 202 | 2003 |
| A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial M Than, S Aldous, SJ Lord, S Goodacre, CMA Frampton, R Troughton, ... JAMA internal medicine 174 (1), 51-58, 2014 | 200 | 2014 |
| Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007 PM George, W Banya, N Pareek, D Bilton, P Cullinan, ME Hodson, ... Bmj 342, 2011 | 187 | 2011 |
| Isolation and properties of recombinant DNA produced variants of human alpha 1-proteinase inhibitor. J Travis, M Owen, P George, R Carrell, S Rosenberg, RA Hallewell, ... Journal of Biological Chemistry 260 (7), 4384-4389, 1985 | 178 | 1985 |
| Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure CH Strey, JM Young, SL Molyneux, PM George, CM Florkowski, RS Scott, ... Atherosclerosis 179 (1), 201-206, 2005 | 163 | 2005 |
| Coenzyme Q10: is there a clinical role and a case for measurement? SL Molyneux, JM Young, CM Florkowski, M Lever, PM George The Clinical Biochemist Reviews 29 (2), 71, 2008 | 161 | 2008 |
